Vaccine Delivery Devices Market Poised for 7 1% CAGR Surge, Forecasting US$5,160 0 Million Valuation by 2030 | Persistence Market Research forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Fact.MR – A Market Research and Competitive Intelligence Provider: The vaccine delivery systems market was valued at US$ 3.81 billion in 2021, and is expected to reach US$ 4.14 billion by the end of 2022, reflecting an increase of 8.6% year over year.
Vaccine delivery devices market: Key Findings
North America owns the largest share in vaccine delivery device market. The market growth is supported by robust and advance medical infrastructure and growing awareness regarding vaccination.
Huge investment in research and development of new vaccine devices fuels the market growth in Europe.
Asia-Pacific region is forecast to observe tremendous growth owing to rising population and low vaccination rates along with rapid infrastructure development.
Intramuscular vaccine is gaining popularity among patients and is estimated to reach the valuation of US$ 1000 Mn by the end of 2022.
Syringes will also register healthy growth in global vaccine delivery device market owing to high utility during mass vaccination and inexpensive nature.
hirenMay 4, 2021
Vaccine Delivery Devices Market. The
Global Vaccine Delivery Devices Market Research Report Covers, Future Trends, Size, Share, Past, Present Data and Deep Analysis, And Forecast, 2021-2027. To calculate the market size, the report considers revenue generated from the sales of products under the scope of the report. The report also considers the revenues to be generated from the sales of the product, which is expected to be launched into the market during the forecast period. This well-drafted report involves the current market status, historical data, and prediction outlook.
The top Major Competitive Players are :
SCHOTT AG; Becton Dickinson & Company; PharmaJet; Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.); Corium International, Inc.; Vaxxas; Gerresheimer AG; and 3M.